Tags

Type your tag names separated by a space and hit enter

Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review.
J Intern Med. 2002 Aug; 252(2):107-13.JI

Abstract

The popularity of Chinese herbal medicines (CHMs) demands a critical analysis of safety issues. The aim of this systematic review is to summarize data regarding adulterations of CHMs with conventional drugs. Literature searches were carried out in six databases. Articles containing original data on adulterations were considered without language restrictions. Eighteen case reports, two case series and four analytical investigations were identified. The list of adulterants contains drugs associated with serious adverse effects like corticosteroids. In several instances, patients were seriously harmed. One report from Taiwan suggests that 24% of all samples were contaminated with at least one conventional pharmacological compound. It is concluded that adulteration of CHMs with synthetic drugs is a potentially serious problem which needs to be addressed by adequate regulatory measures.

Authors+Show Affiliations

Department of Complementary Medicine, School of Sport and Health Sciences, University of Exeter, Exeter, UK. e.ernest@exeter.ac.uk

Pub Type(s)

Journal Article
Review
Systematic Review

Language

eng

PubMed ID

12190885

Citation

Ernst, E. "Adulteration of Chinese Herbal Medicines With Synthetic Drugs: a Systematic Review." Journal of Internal Medicine, vol. 252, no. 2, 2002, pp. 107-13.
Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med. 2002;252(2):107-13.
Ernst, E. (2002). Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. Journal of Internal Medicine, 252(2), 107-13.
Ernst E. Adulteration of Chinese Herbal Medicines With Synthetic Drugs: a Systematic Review. J Intern Med. 2002;252(2):107-13. PubMed PMID: 12190885.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. A1 - Ernst,E, PY - 2002/8/23/pubmed PY - 2002/9/17/medline PY - 2002/8/23/entrez SP - 107 EP - 13 JF - Journal of internal medicine JO - J Intern Med VL - 252 IS - 2 N2 - The popularity of Chinese herbal medicines (CHMs) demands a critical analysis of safety issues. The aim of this systematic review is to summarize data regarding adulterations of CHMs with conventional drugs. Literature searches were carried out in six databases. Articles containing original data on adulterations were considered without language restrictions. Eighteen case reports, two case series and four analytical investigations were identified. The list of adulterants contains drugs associated with serious adverse effects like corticosteroids. In several instances, patients were seriously harmed. One report from Taiwan suggests that 24% of all samples were contaminated with at least one conventional pharmacological compound. It is concluded that adulteration of CHMs with synthetic drugs is a potentially serious problem which needs to be addressed by adequate regulatory measures. SN - 0954-6820 UR - https://www.unboundmedicine.com/medline/citation/12190885/full_citation L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0954-6820&date=2002&volume=252&issue=2&spage=107 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.